The global healthcare staffing market is projected to grow from USD 45.08 billion in 2025 to USD 76.51 billion by 2033, at a CAGR of 6.87%. Growth is driven by rising patient demand, aging populations, healthcare workforce shortages, and increased adoption of digital staffing platforms and telehealth services. However, labor shortages and regulatory complexities pose challenges to market expansion.
Cross Country Healthcare Inc (CCRN)
Common Stock · Currency in USD · XNAS
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
Company Info
SIC7363
Composite FIGIBBG000DGM5N8
CIK0001141103
IPOOct 25, 2001
Sectorservices-help supply services
Highlights
Market Cap$295.59M
EPS-$0.60
P/E Ratio-15.48
Revenue$1.05B
Gross Profit$203.71M
Net Income-$19.10M
Employees1,106
WSO32,199,207
Phone(800) 347-2264
Related Tickers
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cross Country Healthcare Inc, comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Cross Country Healthcare Inc (CCRN) has returned 13.05% so far this year and -35.71% over the past 12 months. Looking at the last ten years, CCRN has achieved an annualized return of -2.22%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
CCRN
1M2.57%
6M-30.61%
YTD13.05%
1Y-35.71%
5Y-6.49%
10Y-2.22%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Cross Country Healthcare Inc (CCRN) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.78% | -6.35% | 9.05% | -2.03% | ||||||||
| 2025 | 0.22% | -5.71% | -13.43% | -8.82% | -2.44% | -1.21% | 3.22% | 0.45% | 6.45% | -12.74% | -16.31% | -21.36% |
| 2024 | -6.14% | -14.63% | 2.80% | -6.93% | -13.90% | -8.34% | 28.45% | -13.86% | -9.74% | -13.95% | -5.61% | 70.20% |
| 2023 | 4.48% | -4.24% | -15.90% | -2.35% | 15.86% | 10.25% | -7.56% | 0.35% | -3.95% | -7.43% | -12.02% | 11.47% |
| 2022 | -22.63% | 3.91% | -2.83% | -14.04% | -6.07% | 16.17% | 27.84% | -2.42% | 13.16% | 29.50% | -4.54% | -25.99% |
| 2021 | -1.46% | 25.96% | 11.02% | 9.05% | 17.05% | 5.29% | -0.73% | 31.98% | -2.79% | -2.49% | 26.25% | 5.03% |
| 2020 | -14.58% | -5.11% | -28.98% | 4.31% | -2.10% | 0.49% | 5.62% | -2.29% | 1.25% | 20.03% | 8.48% | -0.34% |
| 2019 | 33.01% | -9.34% | -19.75% | -0.84% | 0.57% | 31.74% | -0.21% | 0.10% | 0.78% | 4.04% | 10.53% | -3.57% |
| 2018 | 10.40% | -6.09% | 7.45% | 13.33% | -3.48% | -8.16% | 4.64% | -15.10% | -12.35% | 1.26% | 2.14% | -19.98% |
| 2017 | -7.83% | 6.25% | -8.42% | -3.12% | -17.74% | 11.58% | -8.98% | 4.38% | 14.85% | -4.01% | -0.87% | -6.59% |
| 2016 | 7.90% | 8.79% | 3.03% | 5.03% | -17.27% | -3.05% | -5.26% | 27.69% | 9.08% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Cross Country Healthcare Inc (CCRN) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of CCRN compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Cross Country Healthcare Inc volatility is 2.82%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 448.95M | 589.25M | 679.32M | 947.84M | 732.81M | 356.97M | 382.37M | 427.00M | 467.69M | 388.38M | 366.10M | 325.13M | 248.24M | 305.92M | 335.91M |
| Equity Attributable To Parent (USD) | 322.82M | 418.96M | 473.39M | 457.22M | 297.53M | 154.38M | 162.63M | 217.53M | 237.09M | 151.24M | 140.85M | 129.88M | 160.67M | 209.12M | 249.30M |
| Equity Attributable To Noncontrolling Interest (USD) | - | - | - | - | - | 534.00K | 868.00K | 670.00K | 630.00K | 559.00K | 496.00K | 454.00K | - | - | - |
| Equity (USD) | 322.82M | 418.96M | 473.39M | 457.22M | 297.53M | 154.91M | 163.50M | 218.20M | 237.72M | 151.80M | 141.34M | 130.33M | 160.67M | 209.12M | 249.30M |
| Other Non-current Liabilities (USD) | - | - | - | - | - | - | 62.44M | 44.78M | - | - | - | - | - | - | - |
| Long-term Debt (USD) | - | - | - | - | - | - | 70.97M | 78.64M | - | - | - | - | - | - | - |
| Noncurrent Liabilities (USD) | 48.37M | 49.89M | 57.34M | 218.98M | 235.51M | 108.64M | 133.41M | 123.42M | 135.38M | 139.48M | 138.71M | 127.81M | 42.67M | 24.21M | 40.26M |
| Other Current Liabilities (USD) | 49.38M | 72.76M | 96.29M | 199.04M | 134.19M | 57.88M | 54.16M | 52.05M | 60.32M | 63.85M | 56.64M | 38.27M | 25.76M | 50.94M | 30.02M |
| Wages (USD) | 28.38M | 47.65M | 52.30M | 72.61M | 65.58M | 35.54M | 31.31M | 33.33M | 34.27M | 33.24M | 29.40M | 28.73M | 19.15M | 21.65M | 16.33M |
| Current Liabilities (USD) | 77.76M | 120.40M | 148.59M | 271.64M | 199.77M | 93.42M | 85.47M | 85.39M | 94.59M | 97.09M | 86.05M | 67.00M | 44.91M | 72.59M | 46.35M |
| Liabilities (USD) | 126.13M | 170.29M | 205.92M | 490.62M | 435.28M | 202.06M | 218.87M | 208.81M | 229.97M | 236.58M | 224.75M | 194.80M | 87.58M | 96.80M | 86.61M |
| Other Non-current Assets (USD) | 99.95M | 183.22M | 182.36M | 207.78M | 208.70M | 161.51M | 187.19M | 142.89M | 157.04M | 97.71M | 196.88M | 181.82M | 158.14M | 152.32M | 219.08M |
| Intangible Assets (USD) | 27.64M | 42.19M | 54.47M | 44.72M | - | - | - | 75.58M | 87.68M | 72.24M | - | - | - | - | - |
| Fixed Assets (USD) | 27.78M | 28.85M | 27.34M | 19.66M | 15.83M | 12.35M | 11.83M | 13.63M | 14.09M | 12.82M | 10.47M | 12.13M | 6.17M | 8.23M | 12.02M |
| Noncurrent Assets (USD) | 155.36M | 254.25M | 264.16M | 272.17M | 224.54M | 173.86M | 199.02M | 232.10M | 258.80M | 182.77M | 207.35M | 193.95M | 164.31M | 160.56M | 231.10M |
| Other Current Assets (USD) | 286.03M | 327.15M | 407.47M | 664.61M | 500.63M | 177.66M | 177.26M | 188.70M | 203.60M | 199.49M | 154.22M | 125.11M | 77.77M | 139.79M | 97.37M |
| Prepaid Expenses (USD) | 7.56M | 7.85M | 7.68M | 11.07M | 7.65M | 5.46M | 6.10M | 6.21M | 5.29M | 6.13M | 4.52M | 6.07M | 6.16M | 5.58M | 7.44M |
| Current Assets (USD) | 293.59M | 335.00M | 415.15M | 675.67M | 508.27M | 183.11M | 183.36M | 194.91M | 208.89M | 205.61M | 158.75M | 131.18M | 83.93M | 145.37M | 104.81M |
| Assets (USD) | 448.95M | 589.25M | 679.32M | 947.84M | 732.81M | 356.97M | 382.37M | 427.00M | 467.69M | 388.38M | 366.10M | 325.13M | 248.24M | 305.92M | 335.91M |
News and Insights
The M&A Class Action Firm is investigating the proposed mergers of EMCORE Corporation, Cross Country Healthcare, Inc., William Penn Bancorporation, and AlloVir, Inc. and encouraging shareholders to act now.
Halper Sadeh LLC is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed sales of Cross Country Healthcare, EnLink Midstream, Interpublic Group, and Enterprise Bancorp.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, RKDA, ENLC on Behalf of Shareholdersneutral
Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to the proposed sales of Cross Country Healthcare, Arcadia Biosciences, and EnLink Midstream.
The UAE dietary supplements market is projected to grow at a robust CAGR of 7.28% by 2029, driven by increasing health consciousness and rising disposable incomes among consumers. The market is experiencing a surge in demand for diverse supplement offerings to meet various health needs.
Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.
Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decreased by 13.98% from the previous average price target of $23.25. Interpreting Analyst Ratings: A Closer Look A clear picture of Cross Country Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Bill Sutherland Benchmark Lowers Buy $19.00 $21.00 Kevin Steinke Barrington Research Lowers Outperform $24.00 $26.00 Tobey Sommer Truist Securities Lowers Hold $16.00 $22.00 Bill Sutherland Benchmark Lowers Buy $21.00 $24.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cross Country Healthcare. This information offers a snapshot of how analysts perceive the current state ...Full story available on Benzinga.com
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CAR, CCRN and ECPG have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2023.
4 analysts have expressed a variety of opinions on Cross Country Healthcare (NASDAQ:CCRN) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 1 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 1 0 0 Analysts have recently evaluated Cross Country Healthcare and provided 12-month price targets. The average target is $21.25, accompanied by a high estimate of $26.00 and a low estimate of $16.00. This current average represents a 15.0% decrease from the previous average price target of $25.00. Diving into Analyst Ratings: An In-Depth Exploration The perception of Cross Country Healthcare by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Tobey Sommer Truist Securities Lowers Hold $16.00 $22.00 Bill Sutherland Benchmark Lowers Buy $21.00 $24.00 A.J. Rice UBS Announces Neutral $22.00 - Kevin Steinke Barrington Research Lowers Outperform $26.00 $29.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cross Country Healthcare. This offers insight into analysts' perspectives on the current state of the company. Rating: Analyzing trends, analysts offer qualitative evaluations, ranging ...Full story available on Benzinga.com